1. A pilot trial of onabotulinumtoxinA for the treatment of cervicothoracic myofascial pain. (8th August 2011) Authors: Davis, Thomas L.; Fang, John Y.; Gill, Chandler E.; Charles, P. David Journal: Botulinum journal Issue: Volume 2:Number 1(2011) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. ABSTRACTS. (1st January 2013) Journal: Botulinum journal Issue: Volume 2:Number 3/4(2013) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Biochemical, functional and potency characteristics of type A botulinum toxin in clinical use. (26th June 2008) Authors: Panjwani, Naveed; O'Keeffe, Roderic; Pickett, Andy Journal: Botulinum journal Issue: Volume 1:Number 1(2008) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Botulinum Neurotoxin (BoNT) therapeutics: Time to think outside the BoNT?. (18th February 2010) Authors: Larsen, Joseph C. Journal: Botulinum journal Issue: Volume 1:Number 3(2009) Page Start: 261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Botulinum neurotoxins: from the gut to the nervous system. (2015) Authors: Connan, Chloé; Popoff, Michel R. Journal: Botulinum journal Issue: Volume 3:Number 1(2015) Page Start: 55 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Botulism mortality in the USA, 1975-2009. (2015) Authors: Jackson, Kelly A.; Mahon, Barbara E.; Copeland, John; Fagan, Ryan P. Journal: Botulinum journal Issue: Volume 3:Number 1(2015) Page Start: 6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Cloning, expression and purification of botulinum neurotoxin type A heavy chain – crystallographic evidence for a putative tetrameric pore. (6th November 2012) Authors: Lakshminarasimhan, Damodharan; Kumaran, Desigan; Agarwal, Rakhi; Singh, Bal Ram; Swaminathan, Subramanyam Journal: Botulinum journal Issue: Volume 2:Number 2(2012) Page Start: 135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Commentary: Is the scare of the new botulinum serotype over?. (2015) Authors: Singh, Bal Ram Journal: Botulinum journal Issue: Volume 3:Number 1(2015) Page Start: 79 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Comparison of Clostridium botulinum genomes shows the absence of cold shock protein coding genes in type E neurotoxin producing strains. (1st January 2013) Authors: Söderholm, Henna; Jaakkola, Kaisa; Somervuo, Panu; Laine, Pia; Auvinen, Petri; Paulin, Lars; Lindström, Miia; Korkeala, Hannu Journal: Botulinum journal Issue: Volume 2:Number 3/4(2013) Page Start: 189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Comparison of the structural features of botulinum neurotoxin and NTNH, a non-toxic accessory protein of the progenitor complex. (26th June 2008) Authors: Krebs, Kristine M.; Lebeda, Frank J. Journal: Botulinum journal Issue: Volume 1:Number 1(2008) Page Start: 116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗